Article: Java’s Dr. James McRedmond’s Platelet Aggregation Piece is Now Available on

Interested in platelet aggregation for clinical trials?

Check out this article by Java’s Chief Scientific Officer, Dr. James McRedmond, which features on the Drug Information Association’s website:

The piece analyzes platelet aggregation quality control during a multicenter phase 2 clinical trial.